AngioDynamics Gains FDA IDE Approval for RELIEF BPH Study
AngioDynamics Receives FDA Approval to Launch RELIEF Study Evaluating NanoKnife Technology for Benign Prostatic Hyperplasia AngioDynamics, Inc., a medical technology company focused on advancing innovative therapies that improve vascular health,…
Latin Clinical Trial Center Joins PhaseWell Research to Strengthen Clinical Research Access in Puerto Rico
Latin Clinical Trial Center Becomes Part of PhaseWell Research, Expanding Research and Therapeutic Access PhaseWell Research, a rapidly growing multisite clinical research organization dedicated to expanding access to clinical trials…
Oligomerix Secures $1.9 Million NIH Phase II SBIR Fast-Track Grant to Advance OLX-07010 Toward Alzheimer’s Clinical Trials
Oligomerix Receives $1.9 Million NIH Grant to Advance Oral Tau-Targeting Therapy for Alzheimer’s Disease Oligomerix, Inc., a privately held clinical-stage biotechnology company focused on developing novel treatments for Alzheimer’s disease…
Gossamer Bio Reports Final Results of Convertible Notes Exchange Offer and Consent Solicitation
Gossamer Bio Announces Final Results of Convertible Notes Exchange Offer, Strengthening Financial Position Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on advancing therapies for pulmonary hypertension, has announced the…
Neuron23 Expands NEULARK Phase 2 Trial with Support from The Michael J. Fox Foundation
Neuron23 Secures $2.5 Million Grant from The Michael J. Fox Foundation to Expand Precision Medicine Parkinson’s Trial into Israel Neuron23 Inc., a clinical-stage biotechnology company focused on advancing precision medicine…
Deciphera Pharmaceuticals Doses First Patient in Pivotal Phase 3 INTREPID Trial of Sapablursen for Polycythemia Vera
Deciphera Pharmaceuticals Launches Global Phase 3 INTREPID Trial of Sapablursen for Polycythemia Vera Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd., has announced a significant milestone in the development…
Jazz Pharmaceuticals and AbCellera Partner to Develop Next-Generation T-Cell Engaging Multispecific Antibodies
Jazz Pharmaceuticals and AbCellera Partner to Advance Next-Generation T-Cell Engaging Antibodies for Gastrointestinal and Solid Tumors Jazz Pharmaceuticals and AbCellera have entered into a strategic research collaboration aimed at discovering…
Xenco Medical Secures 2026 World Changing Ideas Award from Fast Company
Xenco Medical Earns Fast Company’s 2026 World Changing Ideas Award for Transforming Surgical Care and Digital Health Xenco Medical has achieved another major milestone in its growing list of global…
Hologic Prevails Over Siemens in Key Patent Battle Related to Breast Cancer Detection
Hologic Secures Major Patent Victory Against Siemens in European Mammography Technology Dispute Hologic has announced a significant legal victory in Europe after the Unified Patent Court (UPC) in Germany ruled…
BioTools Innovator VANGUARD Launches ReadyDetect Blood Collection Prize Challenge
BioTools Innovator VANGUARD and BARDA Launch ReadyDetect Competition to Advance At-Home Blood Collection Technologies BioTools Innovator VANGUARD, in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), has announced…
Senopsys Celebrates 20 Years of Enhancing Medicine Palatability for Patients Worldwide
Senopsys Celebrates 20 Years of Advancing Patient-Friendly Medicines Through Sensory Science Senopsys, a company recognized for its expertise in sensory science and pharmaceutical palatability solutions, is marking its 20th anniversary…
Aleve® Teams Up with HGTV’s Dave and Jenny Marrs for New Project DIY Campaign
Aleve Launches Project DIY Campaign Featuring Dave and Jenny Marrs to Celebrate Passion Projects and Long-Lasting Pain Relief Aleve®, one of the leading over-the-counter pain relief brands, has unveiled a…